All Curated Mutation Sites in HPV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E1
  
E1^E4
  
E2
  
E5
  
E6
  
E7
  
L1
  
L2
  

Keyword: Papillomavirus Infections-40258896
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 40258896 A130C
E6
E6
Papillomavirus Infections
G
R
S
L
View
2 40258896 A131C
E6
E6
Papillomavirus Infections
G
R
S
L
View
3 40258896 A326G
E6
E6
Papillomavirus Infections
G
R
S
L
View
4 40258896 C127G
E6
E6
Papillomavirus Infections
G
R
S
L
View
5 40258896 C127T
E6
E6
Papillomavirus Infections
G
R
S
L
View
6 40258896 C136T
E6
E6
Papillomavirus Infections
G
R
S
L
View
7 40258896 C341T
E6
E6
Papillomavirus Infections
G
R
S
L
View
8 40258896 C47F
E6
E6
Papillomavirus Infections
G
R
S
L
View
9 40258896 E7D
E6
E6
Papillomavirus Infections
G
R
S
L
View
10 40258896 G249T
E6
E6
Papillomavirus Infections
G
R
S
L
View
11 40258896 R78W
E6
E6
Papillomavirus Infections
G
R
S
L
View
12 40258896 A132C
E6
E6
Papillomavirus Infections
G
R
S
L
View
13 40258896 A213C
E6
E6
Papillomavirus Infections
G
R
S
L
View
14 40258896 A364C
E6
E6
Papillomavirus Infections
G
R
S
L
View
15 40258896 A480T
E6
E6
Papillomavirus Infections
G
R
S
L
View
16 40258896 K35N
E6
E6
Papillomavirus Infections
G
R
S
L
View
17 40258896 N86H
E6
E6
Papillomavirus Infections
G
R
S
L
View
Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.